Acutaas Chemicals Q2 FY27 Revenue Up 42.7% YoY to ₹4,369 Mn
Acutaas Chemicals Limited reported strong financial results for the second quarter and half year ended September 30, 2026. Revenue from operations for Q2 FY27 surged by 42.7% year-on-year to ₹4,369 million (₹3,062 million in Q2 FY26), while Profit After Tax (PAT) increased by 71.4% to ₹1,231 million (₹719 million in Q2 FY26). The company's PAT margin improved to 28.2% from 23.5% in the prior year. For the half year ended September 30, 2026, revenue grew by 49.3% YoY to ₹7,666 million, and PAT rose by 71.0% YoY to ₹1,981 million. The company inaugurated its South Korea manufacturing facility, which is expected to boost its presence in the semiconductor ecosystem. Acutaas Chemicals has revised its FY27 revenue growth guidance upward to around 30% and its EBITDA margin guidance to 38-40%.
Key Highlights
- Q2 FY27 Revenue from operations increased 42.7% YoY to ₹4,369 million.
- Q2 FY27 PAT grew 71.4% YoY to ₹1,231 million, with PAT margin at 28.2%.
- H1 FY27 Revenue up 49.3% YoY to ₹7,666 million; PAT up 71.0% YoY to ₹1,981 million.
- South Korea manufacturing facility inaugurated, targeting semiconductor applications.
- FY27 revenue growth guidance revised to ~30%; EBITDA margin guidance raised to 38-40%.
Price Impact
More from ACUTAAS